Walgreens Boots Alliance (NASDAQ:WBA) announced its earnings results on Wednesday. The pharmacy operator reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.19, MarketWatch Earnings reports. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The company had revenue of $36.31 billion for the quarter, compared to the consensus estimate of $35.01 billion. During the same period in the previous year, the business earned $1.37 EPS. The company’s revenue was up 5.7% on a year-over-year basis.
Shares of WBA opened at $45.26 on Friday. The company has a 50-day simple moving average of $40.18 and a 200-day simple moving average of $39.23. The firm has a market capitalization of $39.10 billion, a P/E ratio of 90.52, a P/E/G ratio of 1.52 and a beta of 0.44. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.32 and a current ratio of 0.67. Walgreens Boots Alliance has a 52 week low of $33.36 and a 52 week high of $56.80.
The company also recently declared a quarterly dividend, which was paid on Friday, December 11th. Shareholders of record on Thursday, November 19th were issued a dividend of $0.4675 per share. This represents a $1.87 dividend on an annualized basis and a yield of 4.13%. The ex-dividend date of this dividend was Wednesday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 39.45%.
Several research firms have recently commented on WBA. Barclays boosted their price target on shares of Walgreens Boots Alliance from $40.00 to $47.00 and gave the company an “equal weight” rating in a report on Friday. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Friday, December 18th. Credit Suisse Group began coverage on shares of Walgreens Boots Alliance in a report on Thursday. They set a “neutral” rating on the stock. The Goldman Sachs Group lowered their price target on shares of Walgreens Boots Alliance from $37.00 to $33.00 and set a “sell” rating on the stock in a report on Tuesday, October 6th. Finally, Mizuho lowered their price target on shares of Walgreens Boots Alliance from $43.00 to $37.00 and set a “neutral” rating on the stock in a report on Friday, September 11th. Four analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $41.93.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Recommended Story: How Do You Make Money With Penny Stocks?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.